Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: A systematic review

International Urogynecology Journal

Volumn 21, Issue 10, 2010, Pages 1285-1300

  Tirumuru, Sahithi ^a   Al Kurdi, Deyaa ^a   Latthe, Pallavi ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bladder pain syndrome; Botulinum toxin; Interstitial cystitis; Intravesical injection

Indexed keywords

BOTULINUM TOXIN A;

BLADDER CONTRACTION; BLADDER PAIN SYNDROME; CLINICAL TRIAL; CYSTALGIA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DYSURIA; HEMATURIA; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; URODYNAMICS;

EID: 77956473613     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-010-1162-9     Document Type: Review

References (24)

1. Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53 (1):60-67
2. Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T et al (2010) Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn 29 (1):191-198
3. Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140:203-206
4. Clemens JQ, Link CL, Eggers PW, Kusek JW, Nyberg LM Jr, McKinlay JB (2007) Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol 177:1390-1394
5. Held PJ, Hanno PM, Wein AJ, Pauly MV, Cahn MA (1990) Epidemiology of interstitial cystitis. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ (eds) Interstitial cystitis. Springer, London, pp 29-48
6. Rovner E, Propert KJ, Brensinger C, Wein AJ, Foy M, Kirkemo A et al (2000) Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology 56:940-945
7. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB (2004) Botulinum toxin A has antinociceptive effects in treating Interstitial cystitis. Urology 64:871-875
8. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Proceedings of the Third Symposium on Systematic Reviews: Behind the Basics, Oxford, England, 4-9 July (Ref Type: Electronic Citation)
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
10. Kuo HC (2005) Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis. Urol Int 75:170-174
11. Kuo HC, Chancellor MB (2009) Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int 104:657-661
12. Carl S, Grosse J, Laschke S (2007) Treatment of interstitial cystitis with botulinum toxin type A. Eur Urol 6:248
13. Pinto RA, Silva A, Lopes T et al (2009) Intra-trigonal injection of botulinum toxin A in patients with bladder pain syndrome-results at 9 months follow up. J Urol 181 (4, supplement): 20, Ref Type: Abstaract
14. Davies A, Chahal R, Inman R, Urwin G (2006) Intravesical botulinum A toxin (Botox)-does it have a role in the management of interstitial cystitis. Eur Urol Suppl 5 (supplements 2):22, Ref Type: Abstaract
15. El-Bahnasy A, Farahat YA, El-Bendary M, Taha MR, El-Damhogy M, Sherif Mourad (2009) A randomized controlled trial of bacillus Calmette-Guerin and botulinum toxin-A for the treatment of refractory interstitial cystitis. UroToday International Journal 2. doi:10.3834/uij.1944-5784.2008.12.06 (Ref Type: Electronic Citation)
16. Manning JA, Dwyer P, Rosamilia A, Murrary C, Thomas E, Beattie K (2009) Prospective randomised double blind study of the effectiveness of botulinum A toxin for treatment of refractory painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct 20 (suppl 2): S87-S88, Ref Type: Abstract
17. Ramsay AK, Small DR, Conn IG (2007) Intravesical botulinum toxin type A in chronic interstitial cystitis: results of a pilot study. Surgeon 5:331-333
18. Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E (2008) Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 179:1031-1034
19. Giannantoni A, Costantini E, De Stasi S, Mearini E, Santaniello F, Vianello A et al (2007) Intravesical passive delivery of botulinum A toxin in patients affected by painful bladder syndrome: a pilot study. Eur Urol 6 (supplements 2):246, Ref Type: Abstract
20. Liu HT, Kuo HC (2007) Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 70:463-468
21. Chuang YC, Kim DK, Chiang PH, Chancellor MB (2008) Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int 102:704-706
22. Tara Frenkl L, Raymond R (2005) Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin N Am 32:89-99
23. Miller JL (2009) Botox as a treatment for interstitial cystitis in women: a randomized placebo controlled trial. University of Washington, Seattle (Ref Type: Electronic Citation)
24. Hanno P, Dmochowski R (2009) Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 28 (4):274-286, Ref Type: Abstract